Levermore Limited – Trademark Portfolio

Entity Type: 99

Levermore Limited holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include OLAAK and NAUGHTYKIT. The owner is based in Hong Kong.

Unit 417,4th Floor,Lippo Centre

Tower Two,No.89 Queensway,Admiralty

Hong Kong 999077 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

OLAAK
OLAAK
Registered 2021

Trademark Classifications

Levermore Limited's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Levermore Limited have?

Levermore Limited has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Levermore Limited file in?

Levermore Limited files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 10 (Medical Apparatus). Class 35 covers advertising; business management; business administration; office functions.

What are Levermore Limited's most well-known trademarks?

Levermore Limited's registered trademark portfolio includes well-known marks such as OLAAK and NAUGHTYKIT. These are among 2 currently registered trademarks in the portfolio.

What is Levermore Limited's trademark registration success rate?

Levermore Limited has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.